Kristal Hurst
Psychiatric/Mental Health · Blaine, TNNPI 1154591055
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $225,375 of the $259,986 with a category attached, or 86.7%. 13 manufacturers reported payments, led by AbbVie at 44.8% of the total. 2025 is the largest year on record at $146,405, more than ten times the $383 reported in 2021. Among psychiatric/mental health clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 477 payments — averaging $545.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$117K
- Axsome Therapeutics, Inc.$93K
- Vanda Pharmaceuticals Inc.$49K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$281
- Alkermes, Inc.$186
- Neurocrine Biosciences, Inc.$130
- plus $378 from 7 others
What the payments were for
- Speaking & faculty fees$225,37587%
- Travel & lodging$28,87711%
- Food & beverage$5,7342%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 174 | $116,549 |
| Axsome Therapeutics, Inc. | 197 | $93,369 |
| Vanda Pharmaceuticals Inc. | 76 | $49,094 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $281 |
| Alkermes, Inc. | 6 | $186 |
| Neurocrine Biosciences, Inc. | 6 | $130 |
| Johnson & Johnson | 1 | $125 |
| Otsuka America Pharmaceutical, Inc. | 5 | $99 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $51 |
| Teva Pharmaceuticals USA, Inc. | 3 | $49 |
| Bausch Health US, LLC | 1 | $20 |
| Adlon Therapeutics L.p. | 1 | $20 |
| Lundbeck LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$259,986 in reported general payments places this provider in the 95th percentile of 1,167 psychiatric/mental health providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FanaptIloperidone | 114 | $251,813 |
| VraylarCariprazine Hcl | 130 | $196,625 |
| Abilify MaintenaAripiprazole | 51 | $135,828 |
| RexultiBrexpiprazole | 65 | $96,752 |
| CaplytaLumateperone Tosylate | 43 | $75,233 |
| LybalviOlanzapine/Samidorphan Malate | 37 | $59,733 |
| Zyprexa RelprevvOlanzapine Pamoate | 12 | $20,892 |
| TrintellixVortioxetine Hydrobromide | 21 | $16,450 |
| Aripiprazole | 208 | $13,552 |
| Asenapine Maleate | 43 | $11,219 |
| Olanzapine | 430 | $9,658 |
| Olanzapine-Fluoxetine HclOlanzapine/Fluoxetine Hcl | 12 | $5,915 |
| Chlorpromazine Hcl | 31 | $4,793 |
| Buspirone Hcl | 275 | $3,976 |
| Fluvoxamine Maleate | 84 | $3,422 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Vanda Pharmaceuticals Inc.Fanapt | $49,094 | $251,813114 claims |
| Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti | $99 | $232,580116 claims |
| AbbVieVraylar | $116,549 | $196,625130 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $281 | $75,23343 claims |
| Alkermes, Inc.Lybalvi | $186 | $59,73337 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $51 | $16,45021 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,167 psychiatric/mental health providers in Tennessee.
Other psychiatric/mental health in Blaine
- Laura MelaroBolivar$682K
- Fay BembryJohnson City$449K
- Kristian DambrinoNashville$449K
- Mary AllenMemphis$422K
- Lauren HansenNashville$263K
- Joshua ThompsonChattanooga$262K
- Kaitlynn EarlsGreeneville$228K
- Tory WoodardCookeville$191K
- Sarah VogelfangerMemphis$94K
- Anna CookJackson$54K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.